| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology and Skin Cancer Research Laboratories, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois
Psoriasis is an immunologically mediated skin disease linked to several different class I major histocompatibility complex alleles. However, the phenotype of the pathogenic lymphocyte and nature of the T cell activating event which triggers conversion of symptomless (PN) skin into psoriatic plaques (PP skin) is unknown. This study extends our previous observations in which autologous blood-derived immunocytes were injected into PN skin engrafted onto SCID mice to produce full-fledged PP lesions. The first question addressed is whether injected CD4+ T cells or CD8+ T cells were responsible for phenotypic conversion of PN to PP skin. In five different patients only CD4+ but not CD8+ T cell lines produced psoriatic lesions. Next, immunological events occurring within PN skin following injection of CD4+ T cells in grafts that had sufficient tissue available for detailed analysis was examined. In two patients, intraepidermal resident CD8+ T cells were induced to proliferate during lesion development, expressing acute activation markers CD25 and CD69. In another patient, injection of CD4+ T cells revealed CD69 expression by intraepidermal CD4+ as well as CD8+ T cells. To explore the molecular basis for local T cell activation and proliferation, we discovered that intraepidermal immunocytes, including both CD4 and CD8+ T cells, expressed surface receptors (ie, CD94, CD158a, CD158b) typically confined to natural killer cells (ie, natural killer receptors; NKRs) accumulated immediately before onset of acute lesions. The presence of NKR bearing immunocytes was also observed in 10 of 15 different biopsies of chronic plaques taken directly from patients, whereas PN skin (n = 8) or normal skin from healthy donors (n = 8), did not contain such NKR positive immunocytes. Of particular relevance to psoriasis is that these NKRs recognize various class I alleles including those typically inherited by psoriatic family members such as HLA-C and HLA-B allotypes. We conclude that injection of CD4+ T cells into PN skin triggers a series of local immunologically mediated stimulatory events that produce further T cell activation and appearance of both CD4 and CD8+ T cells that express NKRs.
This article has been cited by other articles:
 |
|
 |
|
  D. M. Danilenko Review Paper: Preclinical Models of Psoriasis Vet. Pathol., July 1, 2008; 45(4): 563 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Leon, N. Contractor, I. Fuss, T. Marth, E. Lahey, S. Iwaki, A. la Sala, V. Hoffmann, W. Strober, and B. L. Kelsall Antibodies to Complement Receptor 3 Treat Established Inflammation in Murine Models of Colitis and a Novel Model of Psoriasiform Dermatitis J. Immunol., November 15, 2006; 177(10): 6974 - 6982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gilhar, R. Yaniv, B. Assy, S. Serafimovich, Y. Ullmann, and R. S. Kalish Fas Pulls the Trigger on Psoriasis Am. J. Pathol., January 1, 2006; 168(1): 170 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Bowcock and W. O.C.M. Cookson The genetics of psoriasis, psoriatic arthritis and atopic dermatitis Hum. Mol. Genet., April 1, 2004; 13(90001): R43 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Krueger and K. Callis Potential of Tumor Necrosis Factor Inhibitors in Psoriasis and Psoriatic Arthritis Arch Dermatol, February 1, 2004; 140(2): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Skov, K. Kragballe, C. Zachariae, E. R. Obitz, E. A. Holm, G. B. E. Jemec, H. Solvsten, H. H. Ibsen, L. Knudsen, P. Jensen, et al. HuMax-CD4: A Fully Human Monoclonal Anti-CD4 Antibody for the Treatment of Psoriasis Vulgaris Arch Dermatol, November 1, 2003; 139(11): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-P. Xia, B. Li, D. Hylton, M. Detmar, G. D. Yancopoulos, and J. S. Rudge Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis Blood, July 1, 2003; 102(1): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mizukawa, Y. Yamazaki, Y. Teraki, J. Hayakawa, K. Hayakawa, H. Nuriya, M. Kohara, and T. Shiohara Direct Evidence for Interferon-{gamma} Production by Effector-Memory-Type Intraepidermal T Cells Residing at an Effector Site of Immunopathology in Fixed Drug Eruption Am. J. Pathol., October 1, 2002; 161(4): 1337 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Jackman, S. Keerthy, and G. Perry Murine Epidermal Cell Antigen (Skn)-Directed Autoimmunity Induced by Transfer of CD4+ T Cells Ann. Clin. Lab. Sci., April 1, 2002; 32(2): 171 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Granstein New Treatments for Psoriasis N. Engl. J. Med., July 26, 2001; 345(4): 284 - 287. [Full Text] [PDF]
|
|
|
|
|
|
S. Aractingi, N. Briand, C. Le Danff, M. Viguier, H. Bachelez, L. Michel, L. Dubertret, and E. D. Carosella HLA-G and NK Receptor Are Expressed in Psoriatic Skin : A Possible Pathway for Regulating Infiltrating T Cells? Am. J. Pathol., July 1, 2001; 159(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bockelmann, P. Neugebauer, N. Djahan Paseban, M. Huttemann, H. Gollnick, and B. Bonnekoh Suprabasal Overexpression of the hsRPB7 Gene in Psoriatic Epidermis as Identified by a Reverse Transcriptase-Polymerase Chain Reaction Differential Display Model Comparing Psoriasis Plaque Tissue with Peritonsillar Mucosa Am. J. Pathol., February 1, 2001; 158(2): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bonish, D. Jullien, Y. Dutronc, B. B. Huang, R. Modlin, F. M. Spada, S. A. Porcelli, and B. J. Nickoloff Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-{gamma} Production by NK-T Cells J. Immunol., October 1, 2000; 165(7): 4076 - 4085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Homey, M.-C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J.-J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Muller, R. deWaal Malefyt, et al. Up-Regulation of Macrophage Inflammatory Protein-3{alpha}/CCL20 and CC Chemokine Receptor 6 in Psoriasis J. Immunol., June 15, 2000; 164(12): 6621 - 6632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Nickoloff The Immunologic and Genetic Basis of Psoriasis Arch Dermatol, September 1, 1999; 135(9): 1104 - 1110. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
